| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SMTC | Common Stock | Award | $0 | +3,728 | +8.6% | $0.000000 | 47,051 | 04 Mar 2025 | Direct | F1 |
| transaction | SMTC | Common Stock | Award | $0 | +6,952 | +15% | $0.000000 | 54,003 | 04 Mar 2025 | Direct | F2 |
| transaction | SMTC | Common Stock | Tax liability | $193,022 | -5,425 | -10% | $35.58 | 48,578 | 04 Mar 2025 | Direct | |
| transaction | SMTC | Common Stock | Options Exercise | $0 | +12,384 | +25% | $0.000000 | 60,962 | 05 Mar 2025 | Direct | |
| transaction | SMTC | Common Stock | Tax liability | $226,718 | -6,289 | -10% | $36.05 | 54,673 | 05 Mar 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SMTC | Restricted Stock Unit | Options Exercise | $0 | -12,384 | -33% | $0.000000 | 24,770 | 05 Mar 2025 | Common Stock | 12,384 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | The reporting person was granted performance stock units by Semtech in Semtech's fiscal year 2023 that are eligible to vest based on Semtech's relative total stockholder return over a period of one, two and three years. This transaction represents the payment and vesting of the awards with respect to the third year in the performance period. |
| F2 | The reporting person was granted performance stock units by Semtech in Semtech's fiscal year 2024 that are eligible to vest based on Semtech's relative total stockholder return over a period of one, two and three years. This transaction represents the payment and vesting of the awards with respect to the second year in the performance period. |
| F3 | Each stock unit is the economic equivalent of one share of Semtech common stock. |
| F4 | This grant vests in three annual installments beginning on March 5, 2025. |